Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Veterinary Biological Vaccines Market Growth 2022-2028

  • LP 4972167
  • 126 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Veterinary Biological Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Veterinary Biological Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Veterinary Biological Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Veterinary Biological Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Veterinary Biological Vaccines market, reaching US$ million by the year 2028. As for the Europe Veterinary Biological Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Veterinary Biological Vaccines players cover Merck, Zoetis, Boehringer Ingelheim, and Ceva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Biological Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Live Attenuated Vaccines

Inactivated Vaccines

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Livestock

Swine

Chicken

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Yebio

DHN

WINSUN

Elanco

Virbac

CAVAC

Kyoto Biken Laboratories

FATRO

Vaksindo

Bio-Labs

Avimex Animal Health

MEVAC

Biovac

Atafen

Dyntec

Ringpu Biology

Jinyu Bio-technology

Jinhe Biotechnology

China Animal Husbandry Industry

Wuhan Keqian Biology

Pulike Biological Engineering

Chengdu Kanghua Biological Products

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Veterinary Biological Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Veterinary Biological Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Veterinary Biological Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Veterinary Biological Vaccines Segment by Type

2.2.1 Live Attenuated Vaccines

2.2.2 Inactivated Vaccines

2.2.3 Others

2.3 Veterinary Biological Vaccines Sales by Type

2.3.1 Global Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Veterinary Biological Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Veterinary Biological Vaccines Sale Price by Type (2017-2022)

2.4 Veterinary Biological Vaccines Segment by Application

2.4.1 Livestock

2.4.2 Swine

2.4.3 Chicken

2.4.4 Others

2.5 Veterinary Biological Vaccines Sales by Application

2.5.1 Global Veterinary Biological Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Veterinary Biological Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Veterinary Biological Vaccines Sale Price by Application (2017-2022)

3 Global Veterinary Biological Vaccines by Company

3.1 Global Veterinary Biological Vaccines Breakdown Data by Company

3.1.1 Global Veterinary Biological Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Veterinary Biological Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Veterinary Biological Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Veterinary Biological Vaccines Revenue by Company (2020-2022)

3.2.2 Global Veterinary Biological Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Veterinary Biological Vaccines Sale Price by Company

3.4 Key Manufacturers Veterinary Biological Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Veterinary Biological Vaccines Product Location Distribution

3.4.2 Players Veterinary Biological Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Veterinary Biological Vaccines by Geographic Region

4.1 World Historic Veterinary Biological Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Veterinary Biological Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Veterinary Biological Vaccines Annual Revenue by Geographic Region

4.2 World Historic Veterinary Biological Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Veterinary Biological Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Veterinary Biological Vaccines Annual Revenue by Country/Region

4.3 Americas Veterinary Biological Vaccines Sales Growth

4.4 APAC Veterinary Biological Vaccines Sales Growth

4.5 Europe Veterinary Biological Vaccines Sales Growth

4.6 Middle East & Africa Veterinary Biological Vaccines Sales Growth

5 Americas

5.1 Americas Veterinary Biological Vaccines Sales by Country

5.1.1 Americas Veterinary Biological Vaccines Sales by Country (2017-2022)

5.1.2 Americas Veterinary Biological Vaccines Revenue by Country (2017-2022)

5.2 Americas Veterinary Biological Vaccines Sales by Type

5.3 Americas Veterinary Biological Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Veterinary Biological Vaccines Sales by Region

6.1.1 APAC Veterinary Biological Vaccines Sales by Region (2017-2022)

6.1.2 APAC Veterinary Biological Vaccines Revenue by Region (2017-2022)

6.2 APAC Veterinary Biological Vaccines Sales by Type

6.3 APAC Veterinary Biological Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Veterinary Biological Vaccines by Country

7.1.1 Europe Veterinary Biological Vaccines Sales by Country (2017-2022)

7.1.2 Europe Veterinary Biological Vaccines Revenue by Country (2017-2022)

7.2 Europe Veterinary Biological Vaccines Sales by Type

7.3 Europe Veterinary Biological Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Veterinary Biological Vaccines by Country

8.1.1 Middle East & Africa Veterinary Biological Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Veterinary Biological Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Veterinary Biological Vaccines Sales by Type

8.3 Middle East & Africa Veterinary Biological Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Veterinary Biological Vaccines

10.3 Manufacturing Process Analysis of Veterinary Biological Vaccines

10.4 Industry Chain Structure of Veterinary Biological Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Veterinary Biological Vaccines Distributors

11.3 Veterinary Biological Vaccines Customer

12 World Forecast Review for Veterinary Biological Vaccines by Geographic Region

12.1 Global Veterinary Biological Vaccines Market Size Forecast by Region

12.1.1 Global Veterinary Biological Vaccines Forecast by Region (2023-2028)

12.1.2 Global Veterinary Biological Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Veterinary Biological Vaccines Forecast by Type

12.7 Global Veterinary Biological Vaccines Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Veterinary Biological Vaccines Product Offered

13.1.3 Merck Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Zoetis

13.2.1 Zoetis Company Information

13.2.2 Zoetis Veterinary Biological Vaccines Product Offered

13.2.3 Zoetis Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Zoetis Main Business Overview

13.2.5 Zoetis Latest Developments

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Company Information

13.3.2 Boehringer Ingelheim Veterinary Biological Vaccines Product Offered

13.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boehringer Ingelheim Main Business Overview

13.3.5 Boehringer Ingelheim Latest Developments

13.4 Ceva

13.4.1 Ceva Company Information

13.4.2 Ceva Veterinary Biological Vaccines Product Offered

13.4.3 Ceva Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ceva Main Business Overview

13.4.5 Ceva Latest Developments

13.5 CAHIC

13.5.1 CAHIC Company Information

13.5.2 CAHIC Veterinary Biological Vaccines Product Offered

13.5.3 CAHIC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 CAHIC Main Business Overview

13.5.5 CAHIC Latest Developments

13.6 HVRI

13.6.1 HVRI Company Information

13.6.2 HVRI Veterinary Biological Vaccines Product Offered

13.6.3 HVRI Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 HVRI Main Business Overview

13.6.5 HVRI Latest Developments

13.7 Yebio

13.7.1 Yebio Company Information

13.7.2 Yebio Veterinary Biological Vaccines Product Offered

13.7.3 Yebio Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Yebio Main Business Overview

13.7.5 Yebio Latest Developments

13.8 DHN

13.8.1 DHN Company Information

13.8.2 DHN Veterinary Biological Vaccines Product Offered

13.8.3 DHN Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 DHN Main Business Overview

13.8.5 DHN Latest Developments

13.9 WINSUN

13.9.1 WINSUN Company Information

13.9.2 WINSUN Veterinary Biological Vaccines Product Offered

13.9.3 WINSUN Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 WINSUN Main Business Overview

13.9.5 WINSUN Latest Developments

13.10 Elanco

13.10.1 Elanco Company Information

13.10.2 Elanco Veterinary Biological Vaccines Product Offered

13.10.3 Elanco Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Elanco Main Business Overview

13.10.5 Elanco Latest Developments

13.11 Virbac

13.11.1 Virbac Company Information

13.11.2 Virbac Veterinary Biological Vaccines Product Offered

13.11.3 Virbac Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Virbac Main Business Overview

13.11.5 Virbac Latest Developments

13.12 CAVAC

13.12.1 CAVAC Company Information

13.12.2 CAVAC Veterinary Biological Vaccines Product Offered

13.12.3 CAVAC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 CAVAC Main Business Overview

13.12.5 CAVAC Latest Developments

13.13 Kyoto Biken Laboratories

13.13.1 Kyoto Biken Laboratories Company Information

13.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Offered

13.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Kyoto Biken Laboratories Main Business Overview

13.13.5 Kyoto Biken Laboratories Latest Developments

13.14 FATRO

13.14.1 FATRO Company Information

13.14.2 FATRO Veterinary Biological Vaccines Product Offered

13.14.3 FATRO Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 FATRO Main Business Overview

13.14.5 FATRO Latest Developments

13.15 Vaksindo

13.15.1 Vaksindo Company Information

13.15.2 Vaksindo Veterinary Biological Vaccines Product Offered

13.15.3 Vaksindo Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Vaksindo Main Business Overview

13.15.5 Vaksindo Latest Developments

13.16 Bio-Labs

13.16.1 Bio-Labs Company Information

13.16.2 Bio-Labs Veterinary Biological Vaccines Product Offered

13.16.3 Bio-Labs Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Bio-Labs Main Business Overview

13.16.5 Bio-Labs Latest Developments

13.17 Avimex Animal Health

13.17.1 Avimex Animal Health Company Information

13.17.2 Avimex Animal Health Veterinary Biological Vaccines Product Offered

13.17.3 Avimex Animal Health Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Avimex Animal Health Main Business Overview

13.17.5 Avimex Animal Health Latest Developments

13.18 MEVAC

13.18.1 MEVAC Company Information

13.18.2 MEVAC Veterinary Biological Vaccines Product Offered

13.18.3 MEVAC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 MEVAC Main Business Overview

13.18.5 MEVAC Latest Developments

13.19 Biovac

13.19.1 Biovac Company Information

13.19.2 Biovac Veterinary Biological Vaccines Product Offered

13.19.3 Biovac Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Biovac Main Business Overview

13.19.5 Biovac Latest Developments

13.20 Atafen

13.20.1 Atafen Company Information

13.20.2 Atafen Veterinary Biological Vaccines Product Offered

13.20.3 Atafen Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Atafen Main Business Overview

13.20.5 Atafen Latest Developments

13.21 Dyntec

13.21.1 Dyntec Company Information

13.21.2 Dyntec Veterinary Biological Vaccines Product Offered

13.21.3 Dyntec Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Dyntec Main Business Overview

13.21.5 Dyntec Latest Developments

13.22 Ringpu Biology

13.22.1 Ringpu Biology Company Information

13.22.2 Ringpu Biology Veterinary Biological Vaccines Product Offered

13.22.3 Ringpu Biology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Ringpu Biology Main Business Overview

13.22.5 Ringpu Biology Latest Developments

13.23 Jinyu Bio-technology

13.23.1 Jinyu Bio-technology Company Information

13.23.2 Jinyu Bio-technology Veterinary Biological Vaccines Product Offered

13.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Jinyu Bio-technology Main Business Overview

13.23.5 Jinyu Bio-technology Latest Developments

13.24 Jinhe Biotechnology

13.24.1 Jinhe Biotechnology Company Information

13.24.2 Jinhe Biotechnology Veterinary Biological Vaccines Product Offered

13.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Jinhe Biotechnology Main Business Overview

13.24.5 Jinhe Biotechnology Latest Developments

13.25 China Animal Husbandry Industry

13.25.1 China Animal Husbandry Industry Company Information

13.25.2 China Animal Husbandry Industry Veterinary Biological Vaccines Product Offered

13.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 China Animal Husbandry Industry Main Business Overview

13.25.5 China Animal Husbandry Industry Latest Developments

13.26 Wuhan Keqian Biology

13.26.1 Wuhan Keqian Biology Company Information

13.26.2 Wuhan Keqian Biology Veterinary Biological Vaccines Product Offered

13.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Wuhan Keqian Biology Main Business Overview

13.26.5 Wuhan Keqian Biology Latest Developments

13.27 Pulike Biological Engineering

13.27.1 Pulike Biological Engineering Company Information

13.27.2 Pulike Biological Engineering Veterinary Biological Vaccines Product Offered

13.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.27.4 Pulike Biological Engineering Main Business Overview

13.27.5 Pulike Biological Engineering Latest Developments

13.28 Chengdu Kanghua Biological Products

13.28.1 Chengdu Kanghua Biological Products Company Information

13.28.2 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Offered

13.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.28.4 Chengdu Kanghua Biological Products Main Business Overview

13.28.5 Chengdu Kanghua Biological Products Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Veterinary Biological Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Veterinary Biological Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live Attenuated Vaccines

Table 4. Major Players of Inactivated Vaccines

Table 5. Major Players of Others

Table 6. Global Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)

Table 7. Global Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)

Table 8. Global Veterinary Biological Vaccines Revenue by Type (2017-2022) & ($ million)

Table 9. Global Veterinary Biological Vaccines Revenue Market Share by Type (2017-2022)

Table 10. Global Veterinary Biological Vaccines Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Veterinary Biological Vaccines Sales by Application (2017-2022) & (K Units)

Table 12. Global Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)

Table 13. Global Veterinary Biological Vaccines Revenue by Application (2017-2022)

Table 14. Global Veterinary Biological Vaccines Revenue Market Share by Application (2017-2022)

Table 15. Global Veterinary Biological Vaccines Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Veterinary Biological Vaccines Sales by Company (2020-2022) & (K Units)

Table 17. Global Veterinary Biological Vaccines Sales Market Share by Company (2020-2022)

Table 18. Global Veterinary Biological Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Veterinary Biological Vaccines Revenue Market Share by Company (2020-2022)

Table 20. Global Veterinary Biological Vaccines Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Veterinary Biological Vaccines Producing Area Distribution and Sales Area

Table 22. Players Veterinary Biological Vaccines Products Offered

Table 23. Veterinary Biological Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Veterinary Biological Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Veterinary Biological Vaccines Sales Market Share Geographic Region (2017-2022)

Table 28. Global Veterinary Biological Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Veterinary Biological Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Veterinary Biological Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Veterinary Biological Vaccines Sales Market Share by Country/Region (2017-2022)

Table 32. Global Veterinary Biological Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Veterinary Biological Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)

Table 35. Americas Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)

Table 36. Americas Veterinary Biological Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)

Table 38. Americas Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)

Table 39. Americas Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)

Table 40. Americas Veterinary Biological Vaccines Sales by Application (2017-2022) & (K Units)

Table 41. Americas Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)

Table 42. APAC Veterinary Biological Vaccines Sales by Region (2017-2022) & (K Units)

Table 43. APAC Veterinary Biological Vaccines Sales Market Share by Region (2017-2022)

Table 44. APAC Veterinary Biological Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Veterinary Biological Vaccines Revenue Market Share by Region (2017-2022)

Table 46. APAC Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)

Table 47. APAC Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)

Table 48. APAC Veterinary Biological Vaccines Sales by Application (2017-2022) & (K Units)

Table 49. APAC Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)

Table 50. Europe Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)

Table 51. Europe Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)

Table 52. Europe Veterinary Biological Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)

Table 54. Europe Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)

Table 55. Europe Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)

Table 56. Europe Veterinary Biological Vaccines Sales by Application (2017-2022) & (K Units)

Table 57. Europe Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Veterinary Biological Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Veterinary Biological Vaccines Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Veterinary Biological Vaccines

Table 67. Key Market Challenges & Risks of Veterinary Biological Vaccines

Table 68. Key Industry Trends of Veterinary Biological Vaccines

Table 69. Veterinary Biological Vaccines Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Veterinary Biological Vaccines Distributors List

Table 72. Veterinary Biological Vaccines Customer List

Table 73. Global Veterinary Biological Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Veterinary Biological Vaccines Sales Market Forecast by Region

Table 75. Global Veterinary Biological Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Veterinary Biological Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Veterinary Biological Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Veterinary Biological Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Veterinary Biological Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Veterinary Biological Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Veterinary Biological Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Veterinary Biological Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Veterinary Biological Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Veterinary Biological Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Veterinary Biological Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Veterinary Biological Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Veterinary Biological Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Veterinary Biological Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Veterinary Biological Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 93. Merck Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. Merck Veterinary Biological Vaccines Product Offered

Table 95. Merck Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Merck Main Business

Table 97. Merck Latest Developments

Table 98. Zoetis Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. Zoetis Veterinary Biological Vaccines Product Offered

Table 100. Zoetis Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Zoetis Main Business

Table 102. Zoetis Latest Developments

Table 103. Boehringer Ingelheim Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. Boehringer Ingelheim Veterinary Biological Vaccines Product Offered

Table 105. Boehringer Ingelheim Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Boehringer Ingelheim Main Business

Table 107. Boehringer Ingelheim Latest Developments

Table 108. Ceva Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. Ceva Veterinary Biological Vaccines Product Offered

Table 110. Ceva Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Ceva Main Business

Table 112. Ceva Latest Developments

Table 113. CAHIC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 114. CAHIC Veterinary Biological Vaccines Product Offered

Table 115. CAHIC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. CAHIC Main Business

Table 117. CAHIC Latest Developments

Table 118. HVRI Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 119. HVRI Veterinary Biological Vaccines Product Offered

Table 120. HVRI Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. HVRI Main Business

Table 122. HVRI Latest Developments

Table 123. Yebio Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 124. Yebio Veterinary Biological Vaccines Product Offered

Table 125. Yebio Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Yebio Main Business

Table 127. Yebio Latest Developments

Table 128. DHN Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 129. DHN Veterinary Biological Vaccines Product Offered

Table 130. DHN Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. DHN Main Business

Table 132. DHN Latest Developments

Table 133. WINSUN Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 134. WINSUN Veterinary Biological Vaccines Product Offered

Table 135. WINSUN Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. WINSUN Main Business

Table 137. WINSUN Latest Developments

Table 138. Elanco Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 139. Elanco Veterinary Biological Vaccines Product Offered

Table 140. Elanco Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Elanco Main Business

Table 142. Elanco Latest Developments

Table 143. Virbac Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 144. Virbac Veterinary Biological Vaccines Product Offered

Table 145. Virbac Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Virbac Main Business

Table 147. Virbac Latest Developments

Table 148. CAVAC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 149. CAVAC Veterinary Biological Vaccines Product Offered

Table 150. CAVAC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. CAVAC Main Business

Table 152. CAVAC Latest Developments

Table 153. Kyoto Biken Laboratories Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 154. Kyoto Biken Laboratories Veterinary Biological Vaccines Product Offered

Table 155. Kyoto Biken Laboratories Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Kyoto Biken Laboratories Main Business

Table 157. Kyoto Biken Laboratories Latest Developments

Table 158. FATRO Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 159. FATRO Veterinary Biological Vaccines Product Offered

Table 160. FATRO Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. FATRO Main Business

Table 162. FATRO Latest Developments

Table 163. Vaksindo Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 164. Vaksindo Veterinary Biological Vaccines Product Offered

Table 165. Vaksindo Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. Vaksindo Main Business

Table 167. Vaksindo Latest Developments

Table 168. Bio-Labs Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 169. Bio-Labs Veterinary Biological Vaccines Product Offered

Table 170. Bio-Labs Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 171. Bio-Labs Main Business

Table 172. Bio-Labs Latest Developments

Table 173. Avimex Animal Health Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 174. Avimex Animal Health Veterinary Biological Vaccines Product Offered

Table 175. Avimex Animal Health Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 176. Avimex Animal Health Main Business

Table 177. Avimex Animal Health Latest Developments

Table 178. MEVAC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 179. MEVAC Veterinary Biological Vaccines Product Offered

Table 180. MEVAC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 181. MEVAC Main Business

Table 182. MEVAC Latest Developments

Table 183. Biovac Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 184. Biovac Veterinary Biological Vaccines Product Offered

Table 185. Biovac Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 186. Biovac Main Business

Table 187. Biovac Latest Developments

Table 188. Atafen Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 189. Atafen Veterinary Biological Vaccines Product Offered

Table 190. Atafen Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 191. Atafen Main Business

Table 192. Atafen Latest Developments

Table 193. Dyntec Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 194. Dyntec Veterinary Biological Vaccines Product Offered

Table 195. Dyntec Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 196. Dyntec Main Business

Table 197. Dyntec Latest Developments

Table 198. Ringpu Biology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 199. Ringpu Biology Veterinary Biological Vaccines Product Offered

Table 200. Ringpu Biology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 201. Ringpu Biology Main Business

Table 202. Ringpu Biology Latest Developments

Table 203. Jinyu Bio-technology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 204. Jinyu Bio-technology Veterinary Biological Vaccines Product Offered

Table 205. Jinyu Bio-technology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 206. Jinyu Bio-technology Main Business

Table 207. Jinyu Bio-technology Latest Developments

Table 208. Jinhe Biotechnology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 209. Jinhe Biotechnology Veterinary Biological Vaccines Product Offered

Table 210. Jinhe Biotechnology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 211. Jinhe Biotechnology Main Business

Table 212. Jinhe Biotechnology Latest Developments

Table 213. China Animal Husbandry Industry Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 214. China Animal Husbandry Industry Veterinary Biological Vaccines Product Offered

Table 215. China Animal Husbandry Industry Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 216. China Animal Husbandry Industry Main Business

Table 217. China Animal Husbandry Industry Latest Developments

Table 218. Wuhan Keqian Biology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 219. Wuhan Keqian Biology Veterinary Biological Vaccines Product Offered

Table 220. Wuhan Keqian Biology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 221. Wuhan Keqian Biology Main Business

Table 222. Wuhan Keqian Biology Latest Developments

Table 223. Pulike Biological Engineering Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 224. Pulike Biological Engineering Veterinary Biological Vaccines Product Offered

Table 225. Pulike Biological Engineering Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 226. Pulike Biological Engineering Main Business

Table 227. Pulike Biological Engineering Latest Developments

Table 228. Chengdu Kanghua Biological Products Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 229. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Offered

Table 230. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 231. Chengdu Kanghua Biological Products Main Business

Table 232. Chengdu Kanghua Biological Products Latest Developments

List of Figures

Figure 1. Picture of Veterinary Biological Vaccines

Figure 2. Veterinary Biological Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Veterinary Biological Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Veterinary Biological Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Veterinary Biological Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live Attenuated Vaccines

Figure 10. Product Picture of Inactivated Vaccines

Figure 11. Product Picture of Others

Figure 12. Global Veterinary Biological Vaccines Sales Market Share by Type in 2021

Figure 13. Global Veterinary Biological Vaccines Revenue Market Share by Type (2017-2022)

Figure 14. Veterinary Biological Vaccines Consumed in Livestock

Figure 15. Global Veterinary Biological Vaccines Market: Livestock (2017-2022) & (K Units)

Figure 16. Veterinary Biological Vaccines Consumed in Swine

Figure 17. Global Veterinary Biological Vaccines Market: Swine (2017-2022) & (K Units)

Figure 18. Veterinary Biological Vaccines Consumed in Chicken

Figure 19. Global Veterinary Biological Vaccines Market: Chicken (2017-2022) & (K Units)

Figure 20. Veterinary Biological Vaccines Consumed in Others

Figure 21. Global Veterinary Biological Vaccines Market: Others (2017-2022) & (K Units)

Figure 22. Global Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)

Figure 23. Global Veterinary Biological Vaccines Revenue Market Share by Application in 2021

Figure 24. Veterinary Biological Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Veterinary Biological Vaccines Revenue Market Share by Company in 2021

Figure 26. Global Veterinary Biological Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Veterinary Biological Vaccines Revenue Market Share by Geographic Region in 2021

Figure 28. Global Veterinary Biological Vaccines Sales Market Share by Region (2017-2022)

Figure 29. Global Veterinary Biological Vaccines Revenue Market Share by Country/Region in 2021

Figure 30. Americas Veterinary Biological Vaccines Sales 2017-2022 (K Units)

Figure 31. Americas Veterinary Biological Vaccines Revenue 2017-2022 ($ Millions)

Figure 32. APAC Veterinary Biological Vaccines Sales 2017-2022 (K Units)

Figure 33. APAC Veterinary Biological Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. Europe Veterinary Biological Vaccines Sales 2017-2022 (K Units)

Figure 35. Europe Veterinary Biological Vaccines Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Veterinary Biological Vaccines Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Veterinary Biological Vaccines Revenue 2017-2022 ($ Millions)

Figure 38. Americas Veterinary Biological Vaccines Sales Market Share by Country in 2021

Figure 39. Americas Veterinary Biological Vaccines Revenue Market Share by Country in 2021

Figure 40. United States Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Veterinary Biological Vaccines Sales Market Share by Region in 2021

Figure 45. APAC Veterinary Biological Vaccines Revenue Market Share by Regions in 2021

Figure 46. China Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Veterinary Biological Vaccines Sales Market Share by Country in 2021

Figure 53. Europe Veterinary Biological Vaccines Revenue Market Share by Country in 2021

Figure 54. Germany Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Veterinary Biological Vaccines Revenue Market Share by Country in 2021

Figure 61. Egypt Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Veterinary Biological Vaccines in 2021

Figure 67. Manufacturing Process Analysis of Veterinary Biological Vaccines

Figure 68. Industry Chain Structure of Veterinary Biological Vaccines

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390